Abstract:Abstract Abstract 4688 Umbilical cord blood has been increasingly used as a source of hematopoietic stem cells. However, fetal blood recipients had slower hematopoietic engraftment and impaired immune reconstitution. To accelerate myeloid and lymphoid recovery, we used an animal model of newborn blood modeled for cord blood (CB), along with transiently reconstituting progenitor cells from congenic bone marrow with recipients, as sources of stem cells. According to the previous reports that murine transiently reconstituting progenitor cells express the c-kit molecule, but not Sca-1 and lymphohematopoietic lineage markers, Lin-sca-1-c-kit+(c-kit+) were isolated by MACS method. c-kit+ cells population consisted of exclusively of medium- or large-sized blast-like cells, which displayed relatively low proliferative potential in vitro than Lin-sca-1+ (sca-1+) population. After transplantation of CB from DBA/2 mice (H-2d/d, CD45.2), with or without graded numbers of either c-kit+ or sca-1+ cells isolated from BDF1 mice (H-2d/b, CD45.1) bone marrow into lethally irradiated CD45.2 congenic BDF1 mice, hematopoietic engraftment were dynamic investigated. The intermingled transplantation of CB and c-kit+ cells or sca-1+ cells at the dosages of 1×104 or 2.5×104 or 5×104 to recipient mice leads to the quantity of white blood cells and platelets increased to 1×109/L and 1×1012/L at day12, whereas the injection of CB alone resulted in day17. By 2 weeks post-transplantation, congenic BM-derived cells were dominantly found in granulocytes and B lymphocytes, while host cells were dominantly found in T lymphocytes in CB transplantation combined either with c-kit+cells or sca-1+ cells. In cotransplantation with CB and c-kit+cells – engrafted surviving mice, the degree of donor CB cells in the peripheral blood increased progressively over time, while congenic donor BM-derived cells decreased gradually. After 60 weeks cotransplantation with CB and c-kit+ cells, a complete chimerism frequency of CB–derived cells continued to maintain in granulocytes and B lymphocytes, while T lymphocytes were dominantly derived from CB. On the other hand, congenic bone marrow or host-derived cells were the dominant population and CB-derived cells in the peripheral blood were less than 10% after 60 weeks cotransplantation with CB and sca-1+cells. In conclusion, the cotransplantation of CB and congenic c-kit+ cells was able to accelerate early hematopoietic recovery due to congenic marrow cells. But complete or main chimerism of cord blood was formed without or with fewer residual cells of host origin and congenic BM origin in long-term multilineage reconstitution. Thus, this cotransplant model in vivo may be to bring useful information for improving hematopoietic and immune reconstitution in fetal blood recipients. Disclosures: No relevant conflicts of interest to declare.

[Study on Hematopoiesis Reconstitution by Co-Transplant of Human Bone Marrow Mesenchymal Stem Cells and Umbilical Cord Blood CD34(+) Cells at Different Ratios in NOD/SCID Mice].

[Hematopoietic Reconstitution by Co-Transplantation of Human BM-MSCs and UCB CD34+ Cells at Various Times in NOD/SCID Mice].

Experimental Study on Ex Vivo Expanded Hematopoietic Stem/progenitor in the Two Step Culture from Human Umbilical Cord Blood Transplanted into NOD/SCID Mice

[Study of Ex Vivo Expansion of Mouse Hematopoietic Stem/progenitor Cells and the Use of Them for Hematopoiesis Reconstitution].

Experimental Study on Hematopoietic Reconstruction Effects of Peripheral Blood Stem Cells Mobilized by Anti-Cd49d Monoclonal Antibody Plus Rhg-Csf in Mice

Ex Vivo Expansions and Transplantations of Mouse Bone Marrow-Derived Hematopoietic Stem/progenitor Cells

Cotransplantation of human umbilical cord blood-derived stromal cells and human umbilical cord blood-mononuclear cells accelerates hematopoietic reconstruction and engraftment in radiation-injured mice

NOD/SCID Mice Hematopoietic Repopulating Ability of Ex Vivo Expanded Umbilical Cord Hematopoietic Blood Cells Which Co-cultured with MSCs from Human Umbilical Cord Blood

Ex Vivo Expansion and Transplantation of Hematopoietic Stem/progenitor Cells Supported by Mesenchymal Stem Cells from Human Umbilical Cord Blood.

Effects of Expanded Hematopoietic Stem/progenitor Cells on Mouse Hematopoietic Recovery:Rapid Hematopoietic Recovery, Long-Term Engraftment and Endogenous Recovery

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis

Cocultivation of Umbilical Cord Blood CD34+cells with Retro-Transduced Hmscs Leads to Effective Amplification of Long-Term Culture-Initiating Cells

Hematopoietic Reconstitution of Mice Cord Blood Transplantation Combined with Bone Marrow Transient Hematopoietic Progenitor Cell

Experimental Study on Reparative Effect of Human Umbilical Cord Blood Stromal Cells Transplantation on Hematopoietic Damage

[Hematopoietic Repopulating Ability of Human CD34+ Cells and CD34- Cells in NOD/SCID Mice].

[Earlier hematopoietic reconstitution by mouse cord blood transplantation combined with bone marrow c-kit(+) hematopoietic progenitor cells]

Cotransplantation of human umbilical cord blood-derived stromal cells enhances hematopoietic reconstitution and engraftment in irradiated BABL/c mice.

Characteristics of Hematopoietic and Immunologic Reconstitution Following Co-Transplantation of Two Umbilical Cord Blood Units in SCID Mice

[Hematopoietic Reconstitution of Fresh and Cultured Cord Blood CD34+ Cells in NOD/SCID Mice].

Pre-Clinical Trial On The Co-Transplantation Of Mscs And Umbilical Cord Blood Stem Cells.

Effect of hUCBDSCs on homing efficiency and engraftment capability of hematopoietic cells